Back to Search
Start Over
Adjuvant ipilimumab for stage III melanoma: the patient voice
- Source :
- The Lancet Oncology. 18:282-284
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
- Subjects :
- Oncology
medicine.medical_specialty
business.industry
medicine.medical_treatment
Melanoma
MEDLINE
Ipilimumab
medicine.disease
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Monoclonal
medicine
Stage III melanoma
030212 general & internal medicine
business
Adjuvant
medicine.drug
Subjects
Details
- ISSN :
- 14702045
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- The Lancet Oncology
- Accession number :
- edsair.doi...........90c03e4fa626a16afe9560396f7b9c0d